Merck and Japan's Eisai said on Wednesday they will shut down a late-stage study testing an experimental combination therapy ...
In combination with pembrolizumab, for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC). In combination with everolimus, for the treatment of adult patients with ...
Studies evaluating treatment for unresectable hepatocellular carcinoma and metastatic uveal melanoma are highlighted.
Akeso, Inc. (($HK:9926)) announced an update on their ongoing clinical study. Akeso, Inc. is conducting a Phase III clinical study titled A Phase ...
The campaign encourages early detection and inspires the adoption of a healthy lifestyle to prevent liver cancer ...
The “Best Interests Procedure” (BIP) describes UNHCR’s case management framework for asylum-seeking and refugee children. BIP includes the key steps of child protection case management as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback